Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland, has topped out The facility is set to develop next-generation pharmaceutical manufacturing processes from early 2022 A new medicines manufacturing innovation centre that will solve major pharmaceutical industry challenges and accelerate access to affordable medicines has today topped out. Located in Renfrewshire, at the heart of the emerging Advanced Manufacturing Innovation District Scotland (AMIDS), the £35 million...
Glasgow, UK – CPI has today announced an agreement with DFE Pharma, making it the newest partner of the Medicines Manufacturing Innovation Centre collaboration. This partnership will enable the collaboration to draw upon DFE Pharma’s extensive expertise in the development of excipients for oral solid dosage medicines to help address key challenges facing the pharmaceutical industry today. The Medicines Manufacturing Innovation Centre is a collaboration...
In November 2020, Prime Minister Boris Johnson announced a new £20m fund to manufacture medicines and diagnostic equipment in the UK. The scheme is now live and is accepting applications until 30 June 2021. More information is available here. I was pleased to join a call with colleagues from the Department for Business, Energy & Industrial Strategy (BEIS) today, who provided further details on the scheme. The...
New £20 million fund to grow UK life sciences manufacturing opens for applications Applications open for new £20 million fund to support the manufacture of medicines, diagnostics and MedTech in the UK fund will boost the UK offer in life sciences manufacturing, creating economic opportunities and highly skilled jobs across the country supports the government’s ambitions to build back better, ensuring greater resilience in...
Identify companies with manufacturing expertise through the life and chemical sciences directory Medicines Manufacturing Innovation The UK’s first Medicines Manufacturing Innovation Centre (MMIC) is headquartered in Scotland and will be a unique and world-leading facility focusing on: Small molecule and pharmaceutical manufacturing Speeding the development of next-generation medicines Increasing technology opportunities within the medicines supply chain. Industry, academia, healthcare providers and regulators will...
The increasing need to find cost efficiencies in the production of therapeutics combined with a new sense of urgency to secure national supply chains and achieve net zero carbon emissions is leading to a renaissance in manufacturing within the pharmaceutical industry. With the latest innovations in digitalisation and continuous manufacturing and an abundance of high profile collaborations with world-leading pharmaceutical companies, Scotland is at...
CPI has today announced an agreement with Pfizer, making it the newest partner of the Medicines Manufacturing Innovation Centre collaboration. The partnership will enable the Centre to draw upon Pfizer’s expertise within the pharmaceutical sector to help address key challenges and maximise efficiency within the medicines supply chain. The Medicines Manufacturing Innovation Centre is a collaboration between CPI, the University of Strathclyde and founding industry...
The Medicines Manufacturing Innovation Centre today launches a collaboration that will look to develop a scalable, sustainable and more cost-effective medicines manufacturing process for oligonucleotides: short strands of synthetic DNA or RNA. This collaboration with AstraZeneca, Exactmer, Novartis and UK Research & Innovation aims to make the UK the first country in the world to deliver this pioneering production process at a large scale CPI...
CPI has today announced the start of construction at the Medicines Manufacturing Innovation Centre in Renfrewshire, Scotland. The new technology and innovation centre is set to become a unique and world-leading facility offering transformative solutions in small molecule and pharmaceutical manufacturing. It will accelerate the development and industrialisation of next-generation medicines manufacturing innovations and maximise technology opportunities within the medicines supply chain. Industry, academia, healthcare...